The Efficacy of Adductor-Canal-Block (ACB) in Patients After Anterior Cruciate Ligament (ACL) Reconstruction

Glostrup University Hospital, Copenhagen

Status and phase: Completed; Phase 4

Conditions: Anterior Cruciate Ligament Reconstruction

Treatments: Procedure: Ropivacain; Procedure: Saline

Study type: Interventional

Funder types: Other

Identifiers

NCT01212666

SM1-ME-10

Details and patient eligibility

About

The Purpose of this study is to determine whether Adductor-Canal-Block is superior to placebo when it comes to analgetic efficacy after reconstruction of the anterior cruciate ligament.

Enrollment: 50 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18-70 years
• Reconstruction of Anterior Cruciate Ligament
• Written consent
• ASA I-II
• BMI 19-35

Exclusion criteria

• Unable to communicate in Danish
• Allergic reactions toward drugs used in the trial
• Pregnancy
• Abuse of alcohol/drugs
• Daily opioid intake
• Infection at injection site
• Can not be mobilised to 5 meters of walk; pre-surgery

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

50 participants in 2 patient groups, including a placebo group

Adductor-Canal-Block, Ropivacain

Experimental group

Description:

25 patients. ACB. 30 mL Ropivacain 7,5 mg/mL. Ultrasound-guided application.

Treatment:

Procedure: Ropivacain

Adductor Canal Block, Placebo (saline)

Placebo Comparator group

Description:

25 patients. ACB. 30 mL Saline. Ultrasound-guided application.

Treatment:

Procedure: Saline